Eupraxia Pharmaceuticals Stock Probability of Future Pink Sheet Price Finishing Over 3.17

EPRXF Stock  USD 3.17  0.06  1.86%   
Eupraxia Pharmaceuticals' future price is the expected price of Eupraxia Pharmaceuticals instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Eupraxia Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Check out Eupraxia Pharmaceuticals Backtesting, Eupraxia Pharmaceuticals Valuation, Eupraxia Pharmaceuticals Correlation, Eupraxia Pharmaceuticals Hype Analysis, Eupraxia Pharmaceuticals Volatility, Eupraxia Pharmaceuticals History as well as Eupraxia Pharmaceuticals Performance.
  
Please specify Eupraxia Pharmaceuticals' target price for which you would like Eupraxia Pharmaceuticals odds to be computed.

Eupraxia Pharmaceuticals Target Price Odds to finish over 3.17

The tendency of Eupraxia Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 3.17 90 days 3.17 
more than 93.0
Based on a normal probability distribution, the odds of Eupraxia Pharmaceuticals to move above the current price in 90 days from now is more than 93.0 (This Eupraxia Pharmaceuticals probability density function shows the probability of Eupraxia Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Eupraxia Pharmaceuticals has a beta of -1.63 suggesting as returns on its benchmark rise, returns on holding Eupraxia Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Eupraxia Pharmaceuticals is expected to outperform its benchmark. Additionally Eupraxia Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming NYSE Composite.
   Eupraxia Pharmaceuticals Price Density   
       Price  

Predictive Modules for Eupraxia Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eupraxia Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eupraxia Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.163.179.58
Details
Intrinsic
Valuation
LowRealHigh
0.153.109.51
Details
Naive
Forecast
LowNextHigh
0.083.9510.36
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.173.173.17
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eupraxia Pharmaceuticals. Your research has to be compared to or analyzed against Eupraxia Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Eupraxia Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eupraxia Pharmaceuticals.

Eupraxia Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Eupraxia Pharmaceuticals is not an exception. The market had few large corrections towards the Eupraxia Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eupraxia Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eupraxia Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.0041
β
Beta against NYSE Composite-1.63
σ
Overall volatility
0.73
Ir
Information ratio -0.05

Eupraxia Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eupraxia Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eupraxia Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Eupraxia Pharmaceuticals generated a negative expected return over the last 90 days
Eupraxia Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (22.99 M) with profit before overhead, payroll, taxes, and interest of 0.
Eupraxia Pharmaceuticals has accumulated about 35.46 M in cash with (14.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Roughly 12.0% of the company shares are held by company insiders

Eupraxia Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eupraxia Pink Sheet often depends not only on the future outlook of the current and potential Eupraxia Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eupraxia Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding14.2 M

Eupraxia Pharmaceuticals Technical Analysis

Eupraxia Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Eupraxia Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Eupraxia Pharmaceuticals. In general, you should focus on analyzing Eupraxia Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.

Eupraxia Pharmaceuticals Predictive Forecast Models

Eupraxia Pharmaceuticals' time-series forecasting models is one of many Eupraxia Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Eupraxia Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.

Things to note about Eupraxia Pharmaceuticals

Checking the ongoing alerts about Eupraxia Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Eupraxia Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Eupraxia Pharmaceuticals generated a negative expected return over the last 90 days
Eupraxia Pharmaceuticals has high historical volatility and very poor performance
Net Loss for the year was (22.99 M) with profit before overhead, payroll, taxes, and interest of 0.
Eupraxia Pharmaceuticals has accumulated about 35.46 M in cash with (14.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66.
Roughly 12.0% of the company shares are held by company insiders

Complementary Tools for Eupraxia Pink Sheet analysis

When running Eupraxia Pharmaceuticals' price analysis, check to measure Eupraxia Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eupraxia Pharmaceuticals is operating at the current time. Most of Eupraxia Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eupraxia Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eupraxia Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eupraxia Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Please note, there is a significant difference between Eupraxia Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eupraxia Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eupraxia Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.